91制片厂手机版,麻豆传媒映画映在线看,国产剧情91制片厂天美

科學(xué)研究

科研成果

[1] Zhang XX, Liu JS, Han LF, Simm G, Guo XK, Zhou XN*: One Health: new evaluation framework launched. Nature 2022, 604:625.

[2] Zhang XX^#, Liu JS^#, Han LF, Xia S, Li S-Z, Li OY, Kassegne KK, Li M, Yin K, Hu QQ, Xiu LS, Zhu YY, Huang LY, Wang XC, Zhang Y, Zhao HQ, Yin JX, Jiang TG, Li Q, Fei SW, Gu SY, Chen FM, Zhou N, Cheng ZL, Xie Y, Li HM, Chen J, Guo ZY, Feng JX, Ai L, Xue JB, Ye Q, Grant L, Song JX, Simm G, Utzinger J, Guo XK*, Zhou XN*: Towards a global One Health index: a potential assessment tool for One Health performance. Infectious Diseases of Poverty. 2022,，11:57.

[3] Fu X, Lyu L, Wang Y, Zhang Y, Guo X, Chen Q, Liu C*: Safety assessment and probiotic characteristics of Enterococcus lactis JDM1. Microb Pathog 2022, 163:105380.

[4] Hong Z, Li L, Zhang L, Wang Q, Xu J, Li S, Zhou XN*: Elimination of Schistosomiasis Japonica in China: From the One Health Perspective. China CDC Wkly 2022, 4:130-4.

[5] Jiang Y, Yuan Z, Liu H, Yin J, Qin Y, Jiang X, Xu J, Cao J, Shen Y*: Intestinal Protozoan Infections in Patients with Diarrhea - Shanghai Municipality, Zhenjiang City, and Danyang City, China, 2011-2015 and 2019-2021. China CDC Wkly 2022, 4:143-7.

[6] Li Y, Zhang L, Xiu L, Wang D, Zeng Y, Wang F, Yin Y, Peng J*: A Multiplex Molecular Assay for Detection of Six penA Codons To Predict Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2022, 66:e0170921.

[7] Liang L, Shen Y, Hu Y, Liu H, Cao J*: cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner. PLoS Pathog 2022, 18:e1010233.

[8] Lin P, Sun J, Lou X, Li D, Shi Y, Li Z, Ma P, Li P, Chen S, Jin W, Liu S, Chen Q, Gao Q, Zhu L, Xu J, Zhu M, Wang M, Liang K, Zhao L, Xu H, Dong K, Li Q, Cheng X*, Chen J*, Guo X*: Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. Gen Psychiatr 2022, 35:e100685.

[9] Lv C, Deng W, Wang L, Qin Z, Zhou X*, Xu J*: Molecular Techniques as Alternatives of Diagnostic Tools in China as Schistosomiasis Moving towards Elimination. Pathogens 2022, 11.

[10] Qian MB, Utzinger J, Li SZ, Montresor A, Zhou XN*: Towards elimination of soil-transmitted helminthiasis in China. Lancet Reg Health West Pac 2022, 22:100455.

[11] Sun L^#, Xiu L^#, Zhang C^#, Xiao Y, Li Y, Zhang L, Ren L*, Peng J*: Detection and classification of SARS-CoV-2 using high-resolution melting analysis. Microb Biotechnol 2022.

[12] Wang DQ, Liang XH, Lu SN, Ding W, Huang J, Wen X, Lv S, Xiao N, Husain L, Zhou XN*: China's long march to malaria elimination: a case of adaptive management. Malar J 2022, 21:38.

[13] Wang H^#, Yan D^#, Li Y^#, Gong Y^#, Mai Y^#, Li B, Zhu X, Wan X, Xie L, Jiang H, Zhang M, Sun M*, Yao Y*, Zhu Y*: Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients. Infect Dis Poverty 2022, 11:15.

[14] Wang Y^#, Gong W^#, Zhou H, Hu Y, Wang L, Shen Y, Yu G*, Cao J*: A Novel miRNA From Egg-Derived Exosomes of Schistosoma japonicum Promotes Liver Fibrosis in Murine Schistosomiasis. Front Immunol 2022, 13:860807.

[15] Zhang J^#, Qiu J^#, Zhou W, Cao J, Hu X, Mi W, Su B, He B*, Qiu J*, Shen L*: Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat Immunol 2022, 23:237-50.

[16] Zhao S, Wang K, Chong MKC, Musa SS, He M, Han L*, He D*, Wang MH: The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: A conceptual model for COVID-19. J Theor Biol 2022, 542:111105.

[17] Zhou XN*: Infectious Diseases of Poverty: progress achieved during the decade gone and perspectives for the future. Infect Dis Poverty 2022, 11:1.

[18] Cai M, Pu B, Wang Y, Lv L, Jiang C, Fu X, Zhang Y, Zhao W, Dong K, Yang Y, Liu Y, Wei Y, Zhang Z, Li J, Guo X, Liu C*, Qin J*: A Plasmid With Conserved Phage Genes Helps Klebsiella pneumoniae Defend Against the Invasion of Transferable DNA Elements at the Cost of Reduced Virulence. Front Microbiol 2022, 13:827545.

[19] Chang C, Yu X, Guo W, Guo C, Guo X*, Li Q*, Zhu Y*: Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future. Front Microbiol 2022, 13:825828.

[20] Jin LL, Deng L, Bartlett M, Ren YP, Lu JH, Chen Q, Pan YX, Wang H, Guo XK and Liu C: A Novel Herbal Extract Blend Product Prevents Particulate Matters-Induced Inflammation by Improving Gut Microbiota and Maintaining the Integrity of the Intestinal Barrier. Nutrients, 2022 (Accepted)

[21] 吳哲元,，王心怡，郭曉奎,，周曉農(nóng),，夏尚,。大數(shù)據(jù)驅(qū)動的全健康決策支持文獻研究。中國衛(wèi)生信息管理雜志,，2022,，19(2):286-292。

[22] 劉婧姝,，張曉溪,，郭曉奎。全健康的起源,、內(nèi)涵及展望,。中國寄生蟲學(xué)與寄生蟲病雜志，2022,，1：1-11,。

[23] 費思偉,，許靖姍，周曉農(nóng),。全健康:人獸共患病防控的新思考,。中國血吸蟲病防治雜志，2022,，1：1-6,。

[24] 周曉農(nóng)。以全健康理念推進人獸共患病預(yù)防與控制,。中國寄生蟲學(xué)與寄生蟲病雜志,，2022，1：12-19,。

[25] 王向澄,，苗力元。芝加哥健康治理數(shù)字化轉(zhuǎn)型研究：以健康云圖的發(fā)展于應(yīng)用為例,，全球城市研究,，2022。（已接收）

[26] 王向澄,，苗力元,。健康治理數(shù)字化轉(zhuǎn)型的發(fā)展與應(yīng)用，全球城市發(fā)展報告,，2022,。（已接收）

[27] 王向澄，張曉旺 ,。醫(yī)聯(lián)體協(xié)作模式的建立及功能性研究,，中國醫(yī)院，2022,。（已接收）

[28] 王向澄,。醫(yī)學(xué)社會學(xué)視角下的女性主義心理學(xué)研究，專著,，2022,。

[29] 錢璟，吳哲元,，郭曉奎,，劉暢。耐藥微生物和抗生素耐藥基因與全健康,。微生物學(xué)通報，2022.

[30] 陳福民,，郭曉奎,，周曉農(nóng),，劉暢?；谖墨I計量分析的動物食品鏈安全研究,。食品工業(yè)，2022,，43(03)：233-238,。